Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Viktoria V. Mortada"'
Autor:
Petr V. Krivorotko, Yana I. Bondarchuk, Roman V. Donskih, Elena K. Zhiltsova, Nikolay S. Amirov, Sergey S. Bagnenko, Antonina V. Chernaya, Roman S. Pesotskiy, Alexander S. Emelyanov, Viktoria V. Mortada, Tengiz T. Tabagua, Larisa P. Gigolaeva, Sergey S. Yerechshenko, Alexander V. Komyakhov, Kirill S. Nikolaev, Konstantin Yu. Zernov, Diana A. Enaldieva, Alexsander A. Bessonov, Anna S. Artemyeva, Ekaterina A. Busko, Vladislav V. Semiglazov, Tatiana Yu. Semiglazova, Vladimir F. Semiglazov, Aleksey M. Belyaev
Publikováno v:
HERALD of North-Western State Medical University named after I.I. Mechnikov. 15:87-95
BACKGROUND: Surgical treatment of breast cancer plays a major role in the combined and complex treatment of patients. The purity of the examined edges of the resected breast tissue is the main indicator of the reliability of the breast-conserving sur
Autor:
Nikolay S. Amirov, Petr V. Krivorotko, Viktoria V. Mortada, Roman V. Donskikh, Roman S. Pesotskiy, Alexander S. Emelyanov, Tengiz T. Tabagua, Larisa P. Gigolaeva, Sergey S. Yerechshenko, Alexander V. Komyakhov, Kirill S. Nikolaev, Konstantin Yu. Zernov, Elena K. Zhiltsova, Yana I. Bondarchuk, Diana A. Enaldieva, Alexander A. Bessonov, Anna S. Artemyeva, Sergey N. Novikov, Ekaterina A. Busko, Tatyana Yu. Semiglazova, Vladimir F. Semiglazov, Alexey M. Belyaev
Publikováno v:
HERALD of North-Western State Medical University named after I.I. Mechnikov. 15:63-71
BACKGROUND: Neoadjuvant systemic therapy for triple-negative and HER2-positive breast cancer can achieve a complete pathologic response in approximately 60% of patients. Pathological complete response to neoadjuvant systemic therapy is a predictive f
Autor:
Diana A. Enaldieva, Roman V. Donskikh, Petr V. Krivorotko, Evgeny N. Imyanitov, Elena K. Zhiltsova, Anna P. Sokolenko, Tengiz T. Tabagua, Nikolay S. Amirov, Roman S. Pesotsky, Laysan F. Shaikhelislamova, Alexander S. Emelyanov, Viktoria V. Mortada, Larisa P. Gigolaeva, Sergey S. Yerechshenko, Alexander V. Komyakhov, Kirill S. Nikolaev, Konstantin Yu. Zernov, Yana I. Bondarchuk, Ruslan M. Paltuev, Alexander A. Bessonov, Anna S. Artemyeva, Vladislav V. Semiglazov, Tatiana Yu. Semiglazova, Vladimir F. Semiglazov, Alexsey M. Belyaev
Publikováno v:
HERALD of North-Western State Medical University named after I.I. Mechnikov. 14:33-42
BACKGROUND: BRCA-associated triple-negative breast cancer does not only have a better overall survival rate, but also a longer recurrence-free period in compatison to patients with sporadic breast cancer. BRCA-associated triple-negative breast cancer
Autor:
Novikov SN; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia., Krivorotko P; Department of Breast Surgery, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia., Bryantseva Z; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia., Akulova I; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia., Emelyanov A; Department of Breast Surgery, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia., Mortada V; Department of Breast Surgery, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia., Ponomareva O; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia., Krzhivitskiy P; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia., Kanaev S; Department of Radiation Oncology and Nuclear Medicine, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia.
Publikováno v:
Radiation oncology journal [Radiat Oncol J] 2023 Dec; Vol. 41 (4), pp. 267-273. Date of Electronic Publication: 2023 Dec 15.